HGD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of HGD Antibodies for investigating homogentisate 1,2-dioxygenase (HGD) protein function. HGD Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HGD, also known as homogentisate 1,2-dioxygenase, plays a crucial role in the catabolism of the amino acids phenylalanine and tyrosine. The enzyme is essential for the breakdown of homogentisic acid, and dysfunction can lead to its accumulation, resulting in conditions such as alkaptonuria. Understanding HGD function is vital for elucidating metabolic pathways and potential therapeutic targets. Research utilizing HGD monoclonal antibodies has advanced knowledge of enzyme regulation and expression patterns in various tissues. Investigating HGD has provided valuable insights into metabolic disease mechanisms and potential treatment strategies. Current studies focus on characterizing HGD's role in different physiological and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of metabolic disorders and contribute to therapeutic development.